XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Treasury Stock
Accumulated Other Comprehensive Income
Additional Paid-in Capital
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at the beginning of the period, treasury stock (in shares)     23      
Balance at beginning of period, (in shares) at Sep. 30, 2022   70,022        
Balance at beginning of period at Sep. 30, 2022 $ 842,748 $ 70 $ (330) $ (5,851) $ 1,203,145 $ (354,286)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted common stock and units (in shares)   1,338        
Vesting of restricted common stock and units 1 $ 1        
Issuance of common stock pursuant to employee stock purchase plan (in shares)   52        
Issuance of common stock pursuant to employee stock purchase plan 2,320       2,320  
Shares repurchased for stock withholdings on restricted stock awards (in shares)   (515)        
Shares withheld for taxes on equity awards (31,253)       (31,253)  
Share-based compensation 20,507       20,507  
Other comprehensive income, net of tax 4,418     4,418    
Net income 55,274         55,274
Balance at end of period, (in shares) at Mar. 31, 2023   70,897        
Balance at end of period at Mar. 31, 2023 894,015 $ 71 $ (330) (1,433) 1,194,719 (299,012)
Balance at end of period, treasury stock (in shares) at Mar. 31, 2023     (23)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at the beginning of the period, treasury stock (in shares)     23      
Balance at beginning of period, (in shares) at Dec. 30, 2022   70,757        
Balance at beginning of period at Dec. 30, 2022 862,544 $ 71 $ (330) (2,567) 1,190,137 (324,767)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted common stock and units (in shares)   212        
Shares repurchased for stock withholdings on restricted stock awards (in shares)   (72)        
Shares withheld for taxes on equity awards (4,878)       (4,878)  
Share-based compensation 9,460       9,460  
Other comprehensive income, net of tax 1,134     1,134    
Net income 25,755         25,755
Balance at end of period, (in shares) at Mar. 31, 2023   70,897        
Balance at end of period at Mar. 31, 2023 894,015 $ 71 $ (330) (1,433) 1,194,719 (299,012)
Balance at end of period, treasury stock (in shares) at Mar. 31, 2023     (23)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at the beginning of the period, treasury stock (in shares)     23      
Balance at the beginning of the period, treasury stock (in shares)     23      
Balance at beginning of period, (in shares) at Sep. 29, 2023   71,013        
Balance at beginning of period at Sep. 29, 2023 947,600 $ 71 $ (330) (3,635) 1,214,203 (262,709)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Stock option exercises (in shares)   5        
Stock option exercises 80       80  
Vesting of restricted common stock and units (in shares)   502        
Issuance of common stock pursuant to employee stock purchase plan (in shares)   59        
Issuance of common stock pursuant to employee stock purchase plan 2,769       2,769  
Shares repurchased for stock withholdings on restricted stock awards (in shares)   (171)        
Shares withheld for taxes on equity awards (12,522)       (12,522)  
Share-based compensation 20,747       20,747  
Issuance of common stock as consideration for acquisition (in shares)   712        
Issuance of common stock as consideration for acquisition 57,733 $ 1     57,732  
Other comprehensive income, net of tax 1,700     1,700    
Net income 27,506         27,506
Balance at end of period, (in shares) at Mar. 29, 2024   72,120        
Balance at end of period at Mar. 29, 2024 1,045,613 $ 72 $ (330) (1,935) 1,283,009 (235,203)
Balance at end of period, treasury stock (in shares) at Mar. 29, 2024     (23)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at the beginning of the period, treasury stock (in shares)     23      
Balance at beginning of period, (in shares) at Dec. 29, 2023   72,088        
Balance at beginning of period at Dec. 29, 2023 1,024,091 $ 72 $ (330) (396) 1,274,928 (250,183)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Vesting of restricted common stock and units (in shares)   43        
Shares repurchased for stock withholdings on restricted stock awards (in shares)   (11)        
Shares withheld for taxes on equity awards (970)       (970)  
Share-based compensation 12,090       12,090  
Issuance of common stock as consideration for acquisition (3,039)       (3,039)  
Other comprehensive income, net of tax (1,539)     (1,539)    
Net income 14,980         14,980
Balance at end of period, (in shares) at Mar. 29, 2024   72,120        
Balance at end of period at Mar. 29, 2024 $ 1,045,613 $ 72 $ (330) $ (1,935) $ 1,283,009 $ (235,203)
Balance at end of period, treasury stock (in shares) at Mar. 29, 2024     (23)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Balance at the beginning of the period, treasury stock (in shares)     23